000 | 04642cam a2200397 a 4500 | ||
---|---|---|---|
001 | 3387298 | ||
003 | BD-DhUL | ||
005 | 20150121171945.0 | ||
008 | 010921s2002 paua b 001 0 eng | ||
010 | _a 2001050327 | ||
020 | _a0683307371 | ||
035 | _a(OCoLC)48057043 | ||
035 | _a(OCoLC)ocm48057043 | ||
035 | _a(NNC)3387298 | ||
040 |
_aBD-DhUL _cBD-DhUL _dOrLoB-B |
||
050 | 0 | 0 |
_aRS403 _b.P75 2002 |
082 | 0 | 0 |
_a615.19 _bWIF |
245 | 0 | 0 |
_aFoye's principles of medicinal chemistry / _c[edited by] David A. Williams, Thomas L. Lemke. |
246 | 3 | 0 | _aPrinciples of medicinal chemistry |
250 | _a5th ed. | ||
260 |
_aPhiladelphia : _bLippincott Williams & Wilkins, _cc2002. |
||
300 |
_axii, 1114 p. : _bill. ; _c29 cm. |
||
365 |
_aIRS _b1500.00 |
||
504 | _aIncludes bibliographical references and indexes. | ||
505 | 0 | 0 |
_tIntroduction: Origins of Medicinal Chemistry / _rWilliam O. Foye -- _gPt. I. _tPrinciples of Drug Discovery -- _tOverview: Drug Design and Development: A Perspective / _rMichael Williams. _g1. _tNatural Products / _rAlice M. Clark. _g2. _tDrug Design and Relationship of Functional Groups to Pharmacologic Activity / _rJames J. Knittel and Robin M. Zavod. _g3. _tMolecular Modeling and Drug Design / _rEric Billings. _g4. _tReceptors and Drug Action / _rTimothy J. Maher and David A. Johnson. _g5. _tDrug Design Through Enzyme Inhibition / _rStephen G. Kerr. _g6. _tPeptide and Protein Drugs / _rMichael Mokotoff. _g7. _tPhysicochemical and Biopharmaceutical Properties of Drug Substances and Pharmacokinetics / _rSunil Jambhekar. _g8. _tDrug Metabolism / _rDavid A. Williams. _g9. _tU.S. Drug Regulation: An Overview / _rDouglas J. Pisano -- _gPt. II. _tPharmacodynamic Agents -- _tOverview: Drug Receptors: A Perspective / _rDavid J. Triggle. _g10. _tDrugs Affecting Cholinergic Neurotransmission / _rDanny L. Lattin and E. Kim Fifer. |
505 | 8 | 0 |
_g11. _tDrugs Affecting Adrenergic Neurotransmission / _rRobert Griffith. _g12. _tSerotonin Receptors and Drugs Affecting Serotonergic Neurotransmission / _rRichard A. Glennon and Malgorzata Dukat. _g13. _tLocal Anesthetics / _rMatthias C. Lu. _g14. _tVolatile Anesthetics / _rTimothy J. Maher. _g15. _tHypnotics / _rWilliam Soine. _g16. _tAntiseizure Drugs / _rBarbara W. Leduc. _g17. _tPsychotherapeutic Drugs: Antipsychotic and Anxiolytic Agents / _rRaymond G. Booth and John L. Neumeyer. _g18. _tHallucinogens, Stimulants, and Related Drugs of Abuse / _rRichard A. Glennon. _g19. _tOpioid Analgesics / _rDavid S. Fries. _g20. _tDrugs Used to Treat Neuromuscular Disorders: Antiparkinsonian and Spasmolytic Agents / _rRaymond G. Booth and John L. Neumeyer. _g21. _tCardiac Agents: Cardiac Glycosides, Antianginal, and Antiarrhythmic Drugs / _rAhmed S. Mehanna. _g22. _tDiuretics / _rGary O. Rankin. _g23. _tAngiotensin Converting Enzyme Inhibitors, Antagonists and Calcium Blockers / _rMarc W. Harrold. |
505 | 8 | 0 |
_g24. _tCentral and Peripheral Sympatholytics and Vasodilators / _rDavid A. Williams. _g25. _tAntihyperlipoproteinemics and Inhibitors of Cholesterol Biosynthesis / _rMarc W. Harrold. _g26. _tAntithrombotics, Thrombolytics, Coagulants and Plasma Extenders / _rRobert B. Palmer. _g27. _tInsulin and Oral Hypoglycemic Drugs / _rRobert A. Wiley. _g28. _tAdrenocorticoids / _rDuane D. Miller, Robert W. Brueggemeier and James T. Dalton. _g29. _tEstrogen, Progestins and Androgens / _rRobert W. Brueggemeier, Duane D. Miller and James T. Dalton. _g30. _tThyroid Function and Thyroid Drugs / _rAli R. Banijamali. _g31. _tCalcium Homeostasis / _rRobin M. Zavod. _g32. _tNonsteroidal Anti-Inflammatory Agents / _rRonald F. Borne. _g33. _tAntihistamines and Related Antiallergic and Antiulcer Agents / _rWendel L. Nelson. _g34. _tAntibiotics and Antimicrobial Agents / _rLester A. Mitscher. _g35. _tAntiparasitic Agents / _rThomas L. Lemke. _g36. _tAntifungal Drugs / _rRobert Griffith and Timothy Tracy. _g37. _tAntimycobacterial Agents / _rThomas L. Lemke. |
505 | 8 | 0 |
_g38. _tCancer and Cancer Chemotherapy / _rPatrick S. Callery and Peter M. Gannett. _g39. _tAntiviral Agents and Protease Inhibitors / _rManohar L. Sethi -- _gPt. III. _tRecent Advances in Drug Discovery. _g40. _tPharmaceutical Biotechnology / _rRobert D. Sindelar. _g41. _tGene Therapy / _rRonald E. Reid. _g42. _tAntisense Therapeutic Agents / _rMarilyn K. Speedie. _g43. _tSelective Estrogen Receptor Modulators / _rV. Craig Jordan -- _tpKa Values for Some Drugs and Miscellaneous Organic Acids and Bases; pH Values for Tissue Fluids / _rDavid A. Williams. |
650 | 0 | _aPharmaceutical chemistry. | |
650 | 2 | _aChemistry, Pharmaceutical. | |
700 | 1 | _aLemke, Thomas L. | |
700 | 1 |
_aWilliams, David A., _d1938- |
|
700 | 1 | _aFoye, William O. | |
900 |
_aAUTH _bTOC |
||
942 |
_2ddc _cBK |
||
999 |
_c34798 _d34798 |